First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors.

Mahalingam D, Harb W, Patnaik A, Bullock A, Watnick RS, Vincent MY, Chen JJ, Wang S, Pestana H, Chao J, Mahoney J, Cieslewicz M, Watnick J.

Open source

DOI: 10.1038/s43856-024-00433-x
Published: 2024-01-13
Container: Commun Med (Lond)
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s43856-024-00433-x,
  title = {First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors.},
  author = {Mahalingam D and  Harb W and  Patnaik A and  Bullock A and  Watnick RS and  Vincent MY and  Chen JJ and  Wang S and  Pestana H and  Chao J and  Mahoney J and  Cieslewicz M and  Watnick J.},
  year = {2024},
  journal = {Commun Med (Lond)},
  doi = {10.1038/s43856-024-00433-x},
  url = {https://doi.org/10.1038/s43856-024-00433-x}
}

RIS

TY  - JOUR
TI  - First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors.
AU  - Mahalingam D
AU  -  Harb W
AU  -  Patnaik A
AU  -  Bullock A
AU  -  Watnick RS
AU  -  Vincent MY
AU  -  Chen JJ
AU  -  Wang S
AU  -  Pestana H
AU  -  Chao J
AU  -  Mahoney J
AU  -  Cieslewicz M
AU  -  Watnick J.
PY  - 2024
JO  - Commun Med (Lond)
DO  - 10.1038/s43856-024-00433-x
UR  - https://doi.org/10.1038/s43856-024-00433-x
ER  -

APA

D, M., W, H., A, P., A, B., RS, W., MY, V., JJ, C., S, W., H, P., J, C., J, M., M, C., & J., W. (2024). First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors.. Commun Med (Lond). https://doi.org/10.1038/s43856-024-00433-x

Source records

europe-pmc · retrieved 2026-09-26T18:20:04.290Z
doaj · retrieved 2026-09-26T18:20:04.292Z